Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 201

1.

The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide.

Steger-Hartmann T, Raschke M, Riefke B, Pietsch H, Sieber MA, Walter J.

Exp Toxicol Pathol. 2009 Nov;61(6):537-52. doi: 10.1016/j.etp.2008.11.004. Epub 2009 Jan 7.

PMID:
19131226
[PubMed - indexed for MEDLINE]
2.

Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.

Grant D, Johnsen H, Juelsrud A, Løvhaug D.

Acta Radiol. 2009 Mar;50(2):156-69. doi: 10.1080/02841850802637808.

PMID:
19160079
[PubMed - indexed for MEDLINE]
3.

A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.

Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ.

Invest Radiol. 2008 Jan;43(1):65-75.

PMID:
18097279
[PubMed - indexed for MEDLINE]
4.

Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.

Pietsch H, Lengsfeld P, Steger-Hartmann T, Löwe A, Frenzel T, Hütter J, Sieber MA.

Invest Radiol. 2009 Apr;44(4):226-33. doi: 10.1097/RLI.0b013e3181998eb7.

PMID:
19252439
[PubMed - indexed for MEDLINE]
5.

Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.

Abraham JL, Thakral C, Skov L, Rossen K, Marckmann P.

Br J Dermatol. 2008 Feb;158(2):273-80. Epub 2007 Dec 7.

PMID:
18067485
[PubMed - indexed for MEDLINE]
6.

Evaluating the role of zinc in the occurrence of fibrosis of the skin: a preclinical study.

Pietsch H, Pering C, Lengsfeld P, Walter J, Steger-Hartmann T, Golfier S, Frenzel T, Hütter J, Weinmann HJ, Sieber MA.

J Magn Reson Imaging. 2009 Aug;30(2):374-83. doi: 10.1002/jmri.21845.

PMID:
19629978
[PubMed - indexed for MEDLINE]
7.

Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.

Fretellier N, Bouzian N, Parmentier N, Bruneval P, Jestin G, Factor C, Mandet C, Daubiné F, Massicot F, Laprévote O, Hollenbeck C, Port M, Idée JM, Corot C.

Toxicol Sci. 2013 Jan;131(1):259-70. doi: 10.1093/toxsci/kfs274. Epub 2012 Sep 12. Erratum in: Toxicol Sci. 2013 Mar;132(1):252.

PMID:
22977165
[PubMed - indexed for MEDLINE]
Free Article
8.

Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions.

Sieber MA, Lengsfeld P, Frenzel T, Golfier S, Schmitt-Willich H, Siegmund F, Walter J, Weinmann HJ, Pietsch H.

Eur Radiol. 2008 Oct;18(10):2164-73. doi: 10.1007/s00330-008-0977-y. Epub 2008 Jun 11.

PMID:
18545998
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of lanthanoids as X-ray contrast agents.

Pietsch H, Jost G, Frenzel T, Raschke M, Walter J, Schirmer H, Hütter J, Sieber MA.

Eur J Radiol. 2011 Nov;80(2):349-56. doi: 10.1016/j.ejrad.2009.10.023. Epub 2009 Dec 16.

PMID:
20006455
[PubMed - indexed for MEDLINE]
10.

Nephrogenic systemic fibrosis in rats treated with erythropoietin and intravenous iron.

Hope TA, High WA, Leboit PE, Chaopathomkul B, Rogut VS, Herfkens RJ, Brasch RC.

Radiology. 2009 Nov;253(2):390-8. doi: 10.1148/radiol.2532090580. Epub 2009 Sep 29.

PMID:
19789237
[PubMed - indexed for MEDLINE]
11.

Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide.

Fretellier N, Idée J, Bruneval P, Guerret S, Daubiné F, Jestin G, Factor C, Poveda N, Dencausse A, Massicot F, Laprévote O, Mandet C, Bouzian N, Port M, Corot C.

Br J Pharmacol. 2012 Feb;165(4b):1151-62. doi: 10.1111/j.1476-5381.2011.01585.x.

PMID:
21740412
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The role of residual gadolinium in the induction of nephrogenic systemic fibrosis-like skin lesions in rats.

Pietsch H, Raschke M, Ellinger-Ziegelbauer H, Jost G, Walter J, Frenzel T, Lenhard D, Hütter J, Sieber MA.

Invest Radiol. 2011 Jan;46(1):48-56. doi: 10.1097/RLI.0b013e3181efd49a.

PMID:
20938346
[PubMed - indexed for MEDLINE]
13.

Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: the role of excess ligand.

Sieber MA, Lengsfeld P, Walter J, Schirmer H, Frenzel T, Siegmund F, Weinmann HJ, Pietsch H.

J Magn Reson Imaging. 2008 May;27(5):955-62. doi: 10.1002/jmri.21368.

PMID:
18425843
[PubMed - indexed for MEDLINE]
14.

Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review.

Sanyal S, Marckmann P, Scherer S, Abraham JL.

Nephrol Dial Transplant. 2011 Nov;26(11):3616-26. doi: 10.1093/ndt/gfr085. Epub 2011 Mar 25. Review.

PMID:
21441397
[PubMed - indexed for MEDLINE]
Free Article
15.

Nephrogenic systemic fibrosis.

Bardin T, Richette P.

Curr Opin Rheumatol. 2010 Jan;22(1):54-8. doi: 10.1097/BOR.0b013e328333bf3d. Review.

PMID:
19881349
[PubMed - indexed for MEDLINE]
16.

Mechanism of NSF: New evidence challenging the prevailing theory.

Newton BB, Jimenez SA.

J Magn Reson Imaging. 2009 Dec;30(6):1277-83. doi: 10.1002/jmri.21980.

PMID:
19937925
[PubMed - indexed for MEDLINE]
17.

Skin gadolinium following use of MR contrast agents in a rat model of nephrogenic systemic fibrosis.

Haylor J, Schroeder J, Wagner B, Nutter F, Jestin G, Idée JM, Morcos S.

Radiology. 2012 Apr;263(1):107-16. doi: 10.1148/radiol.12110881. Epub 2012 Feb 17.

PMID:
22344402
[PubMed - indexed for MEDLINE]
18.

[Nephrogenic systemic fibrosis].

Breitschaft A, Stahlmann R.

Med Monatsschr Pharm. 2009 Oct;32(10):377-82. Review. German.

PMID:
19886227
[PubMed - indexed for MEDLINE]
19.

Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.

Thakral C, Abraham JL.

J Cutan Pathol. 2009 Dec;36(12):1244-54. doi: 10.1111/j.1600-0560.2009.01283.x. Epub 2009 Jul 7.

PMID:
19602073
[PubMed - indexed for MEDLINE]
20.

The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.

Wiedemeyer K, Kutzner H, Abraham JL, Thakral C, Carlson JA, Tran TA, Hausser I, Hartschuh W.

Am J Dermatopathol. 2009 Oct;31(7):674-81. doi: 10.1097/DAD.0b013e3181a1fb55.

PMID:
19633532
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk